American Vanguard Corporation Stock News

PHILADELPHIA, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Berger Montague advises shareholders of American Vanguard Corporation (“AVD”) (NYSE: AVD) about an investigation into AVD's Board of Directors for potential breaches of fiduciary duties to AVD and AVD's shareholders.

PHILADELPHIA, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Berger Montague advises shareholders of American Vanguard Corporation (“AVD”) (NYSE: AVD) about an investigation into AVD's Board of Directors for potential breaches of fiduciary duties to AVD and AVD's shareholders.

PHILADELPHIA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Berger Montague advises shareholders of American Vanguard Corporation (“AVD”) (NYSE: AVD) about an investigation into AVD's Board of Directors for potential breaches of fiduciary duties to AVD and AVD's shareholders.

American Vanguard Corporation (NYSE:AVD ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Anthony Young - Director, Investor Relations Timothy Donnelly - Acting Chief Executive Officer Mark Bassett - Board Member David Johnson - Vice President, Chief Financial Officer & Treasurer Mason Bennett - Vice President, North American Crop, American Vanguard Corp. Confere...

American Vanguard (NYSE: AVD ) stock is falling on Friday after the specialty chemicals company announced its earnings for the second quarter of 2024. The bad news for AVD stockholders starts with the company's diluted earnings per share of -9 cents.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard Corporation (NYSE: AVD) today announced financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights – versus Second Quarter 2023: Net sales of $128.2 million v. $132.8 million Adjusted EBITDA1 of $6.2 million v. $10.7 million Earnings per share of $(0.42) v. $(0.04) First Half of 2024 Financial ...

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard Corporation (NYSE: AVD), today announced that it will report financial results for the second quarter ended June 30, 2024, on Thursday, August 8, 2024, after the close of the stock market. Tim Donelly, Acting CEO, David T. Johnson, VP, CFO and Treasurer, and Mark Bassett, Director will conduct a conference call focusing on operating perf...

27% panic sell-off post Q1 2024 earnings, despite double-digit YoY growth in EBITDA and operating income. Over $500k value of shares bought by three insiders after the significant drop in share price. Healthy financials, with 2024 guidance indicating expectations to surpass net sales and adjusted EBITDA of 2023, despite the suspension of Dacthal sales in the US.